A carregar...
Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib
BACKGROUND: Imatinib mesylate is an inhibitor of the tyrosine kinase Bcr–Abl and a first-line treatment for Philadelphia chromosome-positive chronic myeloid leukaemia (CML). Dermatological side effects include superficial oedema, pustular eruption, lichenoid reactions, erythroderma, and skin rash. D...
Na minha lista:
| Publicado no: | Maxillofac Plast Reconstr Surg |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5714941/ https://ncbi.nlm.nih.gov/pubmed/29230387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40902-017-0136-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|